Nano-biotechnology Market, By Product Type (Nanomaterials, Nanodevices, Nanocarriers, Reagents & Consumables, and Instruments & Tools), By Therapeutics, By Application, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4443
|
Published Date
November 2025
|
Pages
375
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Nano-biotechnology Market size was valued at US$ 171,234.89 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.
Nano-biotechnology combines the principles of nanotechnology and biotechnology to create advanced materials and devices at the molecular and cellular levels, with applications across healthcare, agriculture, and environmental sectors. Significant progress in areas such as targeted drug delivery systems, diagnostics, and bio-imaging has accelerated research and development, with over 350 nanomedicine products currently undergoing clinical trials worldwide. Despite its promise, the sector faces challenges including high production costs and stringent regulatory requirements, which limit large-scale commercialization.
However, growing demand for precision medicine, advanced diagnostic tools, and sustainable agricultural solutions presents substantial opportunities for both startups and established companies to innovate. Collaborative efforts between academic institutions and biotech firms—such as MIT’s partnership with NanoTech Inc.—are further expanding research capabilities, enhancing product pipelines, and reinforcing the sector’s growth potential, even amid cost and regulatory constraints.
Nano-biotechnology Market- Market Dynamics
Precision Innovations and Emerging Applications Drive Growth in the Nano-Biotechnology Market
Nano-biotechnology is transforming the healthcare, agriculture, and environmental sectors by integrating nanotechnology with biological systems to develop innovative solutions. In healthcare, advancements in nanomedicine are enhancing treatment precision and early disease detection. The U.S. National Nanotechnology Initiative highlights developments such as targeted drug delivery systems and advanced diagnostic tools. For example, the FDA has approved several nano-enabled therapeutics, including Doxil, a liposomal formulation of doxorubicin used in cancer therapy. Globally, governments are actively supporting nano-biotechnology research: in 2024, the European Commission allocated over €1.2 billion toward nanotechnology and biotechnology initiatives under Horizon Europe to advance medical research, environmental applications, and sustainable agriculture. In agriculture, nanotechnology enables the creation of smart fertilizers and pesticides, improving crop yields while minimizing environmental impact. The U.S. Department of Agriculture has supported research into nano-based agricultural products that enhance nutrient delivery and strengthen pest resistance, fostering sustainable farming practices worldwide.
Nano-biotechnology Market- Segmentation Analysis:
The Global Nano-biotechnology Market is segmented on the basis of Product Type, Therapeutics, Application, End-User, and Region.
The global nano-biotechnology market is segmented by product type into nanomaterials, nanodevices, nanocarriers, reagents and consumables, and instruments and tools. Nanocarriers lead the market due to their critical role in targeted drug delivery, enabling precise delivery of therapeutics with minimal side effects. Nanomaterials are widely used in diagnostics and therapeutics, supporting innovations in imaging, biosensors, and regenerative medicine. Nanodevices facilitate high-precision applications such as nanoscale biosensing and molecular manipulation, while instruments and tools, along with reagents and consumables, play a supportive but essential role in research and development. Governments around the world are actively funding nanotechnology research and its medical applications to drive healthcare innovation. For example, the U.S. National Nanotechnology Initiative (NNI) and the European Commission’s Horizon Europe program provide substantial funding, infrastructure support, and regulatory frameworks to accelerate the development and safe application of nanocarriers, nanomaterials, and nanodevices in medicine.
The market is also categorized by therapeutic application into cancer, dental, cardiac, orthopedic, and other sectors. Cancer therapeutics dominate the nano-biotechnology segment due to extensive research on targeted drug delivery systems, early diagnostics, and precision oncology treatments. Cardiac applications follow, addressing cardiovascular disorders through nanotechnology-enabled imaging, drug delivery, and tissue repair solutions. Orthopedic and dental applications maintain moderate market focus, particularly in regenerative therapies and biomaterials, while other areas, including neurological and infectious diseases, are emerging segments with growing research interest. Globally, governments are promoting nanotechnology-based therapeutics through dedicated research grants, clinical trial support, and regulatory guidance. For instance, Japan’s Agency for Medical Research and Development (AMED) and India’s Department of Biotechnology actively fund nano-biotechnology initiatives aimed at cancer, cardiovascular, and other high-impact therapeutic areas to improve patient outcomes and healthcare efficiency.
Nano-biotechnology Market- Geographical Insights
The global nano-biotechnology sector is witnessing robust growth, driven by strategic collaborations, acquisitions, and targeted government support. In 2025, the University at Albany’s Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) received a $10 million state grant to advance research in semiconductors, microsystems, and biomedical technologies. This funding facilitates partnerships with over 150 companies, including industry leaders such as GlobalFoundries and IBM, generating an estimated economic impact of $1.6 billion and creating more than 1,750 jobs. In the corporate sphere, Precision NanoSystems, a Canadian company specializing in lipid nanoparticle technologies, was acquired by Cytiva, strengthening capabilities in mRNA vaccine development. These initiatives highlight the sector’s dynamic expansion, fueled by synergistic academic-industry collaborations and strategic corporate consolidations that are accelerating innovation and commercial adoption in nano-biotechnology.
Nano-biotechnology Market- Country Insights
The United States continues to lead the global nano-biotechnology landscape, driven by strategic mergers, acquisitions, and robust government support. In March 2025, AstraZeneca acquired Belgian biotech firm EsoBiotec for up to $1 billion to strengthen its cell therapy portfolio, with a focus on cancer and autoimmune diseases. This move builds on previous investments, including the acquisition of Gracell Biotechnologies for up to $1.2 billion and a $300 million commitment in Maryland to advance cell therapy development. Concurrently, the U.S. National Nanotechnology Initiative continues to fund interdisciplinary research, promoting innovation in nanomedicine, diagnostics, and therapeutic applications. These initiatives highlight the sector’s dynamic expansion, fueled by a combination of strategic corporate actions and strong academic-industry collaboration.
Nano-biotechnology Market- Competitive Landscape:
The competitive landscape of the nano-biotechnology market is characterized by strategic mergers, acquisitions, and collaborations that drive innovation and strengthen market positioning. In 2025, AstraZeneca acquired Belgian biotech firm EsoBiotec for up to $1 billion to expand its cell therapy capabilities, with a particular focus on cancer and autoimmune diseases. Similarly, Sanofi announced plans to acquire UK-based biotech company Vicebio for $1.15 billion to enhance its portfolio of respiratory vaccines. In the United States, the University at Albany’s Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) received a $10 million state grant to advance research in semiconductors and microelectronics, fostering public-private partnerships with firms such as GlobalFoundries and IBM. These strategic initiatives highlight the sector’s dynamic growth, fueled by both corporate activity and institutional support.
Recent Developments:
- In September 2024, researchers at the National Institute of Agricultural Botany (NIAB) developed a diagnostic kit capable of detecting antibiotics in animal feed, along with a nano-mineral biocapsule for targeted delivery of nutrients, drugs, and bioactive molecules, enhancing food safety and precision nutrition.
In September 2024, NanoSyrinx secured £10 million (USD 12.2 million) in funding to develop its innovative nano-syringe delivery platform, enabling precise transport of peptide and protein payloads directly into the cytosol of targeted cells for advanced therapeutic applications.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANO-BIOTECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Carl Zeiss AG
- Danaher Corporation
- GE Healthcare
- Hitachi High-Technologies Corporation
- Illumina, Inc.
- JEOL Ltd.
- Merck KGaA
- Nanobiotix
- Nikon Corporation
- Oxford Instruments plc
- PerkinElmer, Inc.
- Qiagen N.V.
- Shimadzu Corporation
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
- Others
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Nanomaterials
- Nanotubes
- Nanoparticles
- Nanodevices
- Nanochips
- Biosensors
- Nanocarriers
- Liposomes
- Dendrimers
- Reagents & Consumables
- Instruments & Tools
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY THERAPEUTICS- MARKET ANALYSIS, 2019 - 2032
- Cancer
- Dental
- Cardiac
- Orthopedic
- Others
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Drug Delivery
- Diagnostics & Imaging
- Regenerative Medicine
- Tissue Engineering
- Vaccine Development
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Hospitals & Diagnostic Labs
- Academic Institutions
- Others
GLOBAL NANO-BIOTECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nano-biotechnology Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nano-biotechnology Market Snippet by Product Type
2.1.2. Nano-biotechnology Market Snippet by Therapeutics
2.1.3. Nano-biotechnology Market Snippet by Application
2.1.4. Nano-biotechnology Market Snippet by End-User
2.1.5. Nano-biotechnology Market Snippet by Country
2.1.6. Nano-biotechnology Market Snippet by Region
2.2. Competitive Insights
3. Nano-biotechnology Key Market Trends
3.1. Nano-biotechnology Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nano-biotechnology Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nano-biotechnology Market Opportunities
3.4. Nano-biotechnology Market Future Trends
4. Nano-biotechnology Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nano-biotechnology Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Nano-biotechnology Market Landscape
6.1. Nano-biotechnology Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nano-biotechnology Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Nanomaterials
7.1.2.1. Nanotubes
7.1.2.2. Nanoparticles
7.1.3. Nanodevices
7.1.3.1. Nanochips
7.1.3.2. Biosensors
7.1.4. Nanocarriers
7.1.4.1. Liposomes
7.1.4.2. Dendrimers
7.1.5. Reagents & Consumables
7.1.6. Instruments & Tools
8. Nano-biotechnology Market – By Therapeutics
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutics, 2024 & 2032 (%)
8.1.2. Cancer
8.1.3. Dental
8.1.4. Cardiac
8.1.5. Orthopedic
8.1.6. Others
9. Nano-biotechnology Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Drug Delivery
9.1.3. Diagnostics & Imaging
9.1.4. Regenerative Medicine
9.1.5. Tissue Engineering
9.1.6. Vaccine Development
10. Nano-biotechnology Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
10.1.2. Pharmaceutical & Biotechnology Companies
10.1.3. Research Institutes
10.1.4. Hospitals & Diagnostic Labs
10.1.5. Academic Institutions
10.1.6. Others
11. Nano-biotechnology Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Nano-biotechnology Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Nano-biotechnology Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Nano-biotechnology Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Nano-biotechnology Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Nano-biotechnology Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Nano-biotechnology Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Affymetrix, Inc.
12.2.2. Agilent Technologies, Inc.
12.2.3. Becton, Dickinson and Company
12.2.4. Bio-Rad Laboratories, Inc.
12.2.5. Bruker Corporation
12.2.6. Carl Zeiss AG
12.2.7. Danaher Corporation
12.2.8. GE Healthcare
12.2.9. Hitachi High-Technologies Corporation
12.2.10. Illumina, Inc.
12.2.11. JEOL Ltd.
12.2.12. Merck KGaA
12.2.13. Nanobiotix
12.2.14. Nikon Corporation
12.2.15. Oxford Instruments plc
12.2.16. PerkinElmer, Inc.
12.2.17. Qiagen N.V.
12.2.18. Shimadzu Corporation
12.2.19. Tecan Group Ltd.
12.2.20. Thermo Fisher Scientific, Inc.
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
